-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca and MSD announced that their partnership with Liptrex® has successfully expanded medical insurance indications, and its breast cancer indications have been added to the national medical insurance catalogue, further expanding the scope of benefits of this treatment, so that patients who really need it clinically can receive innovative treatment in a more timely and continuous manner.

Zhitongcaijing·12/07/2025 09:17:08
Listen to the news
AstraZeneca and MSD announced that their partnership with Liptrex® has successfully expanded medical insurance indications, and its breast cancer indications have been added to the national medical insurance catalogue, further expanding the scope of benefits of this treatment, so that patients who really need it clinically can receive innovative treatment in a more timely and continuous manner.